+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cosentyx"

Axial spondyloarthritis (axSpA) Market and Forecast Analysis to 2037 - Product Thumbnail Image

Axial spondyloarthritis (axSpA) Market and Forecast Analysis to 2037

  • Drug Pipelines
  • July 2018
  • 393 Pages
  • Global
From
From
From
Market Spotlight: Axial Spondyloarthritis (axSpA) - Product Thumbnail Image

Market Spotlight: Axial Spondyloarthritis (axSpA)

  • Report
  • March 2021
  • 52 Pages
  • Global
Market Spotlight: Psoriatic Arthritis - Product Thumbnail Image

Market Spotlight: Psoriatic Arthritis

  • Report
  • September 2020
  • 65 Pages
  • Global
Digital Landscape: Ankylosing Spondylitis - Product Thumbnail Image

Digital Landscape: Ankylosing Spondylitis

  • Report
  • September 2018
  • 132 Pages
  • Global
From
Cosentyx- Drug Insight, 2019 - Product Thumbnail Image

Cosentyx- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
Psoriatic Arthritis Market and Forecast Analysis 2035 - Product Thumbnail Image

Psoriatic Arthritis Market and Forecast Analysis 2035

  • Drug Pipelines
  • July 2018
  • 503 Pages
  • Global
From
From
Loading Indicator

Cosentyx is a biologic drug used to treat immune disorders such as psoriasis, ankylosing spondylitis, and psoriatic arthritis. It is a monoclonal antibody that works by blocking the action of a protein called interleukin-17A (IL-17A). This protein is involved in the inflammation process, which is a key factor in the development of these disorders. Cosentyx is administered as an injection under the skin or as an intravenous infusion. Cosentyx is a relatively new drug, having been approved by the US Food and Drug Administration in 2015. It is the first and only IL-17A inhibitor approved for the treatment of psoriasis, ankylosing spondylitis, and psoriatic arthritis. It is also the first biologic drug approved for the treatment of ankylosing spondylitis. Cosentyx is marketed by Novartis, a Swiss multinational pharmaceutical company. Other companies in the market include AbbVie, Amgen, and Janssen Biotech. Show Less Read more